Study guide
3.7 3D Conformal Radiation Therapy (3D-CRT) Beam Arrangements
ARRT Radiation Therapy Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Patient Care & Education
1.1 Patient Assessment, History, and Vital Signs 1.2 Psychosocial Support & Coping Mechanisms 1.3 Patient & Family Education on Radiation Therapy 1.4 Radiation Side Effect Management: Skin & Mucosal Reactions 1.5 Radiation Side Effect Management: Systemic & Organ-Specific Side Effects 1.6 Nutritional Support & Management of Dysphagia/Odynophagia 1.7 Medical Emergencies in Radiation Oncology 1.8 Patient Rights, Informed Consent, and Advanced Directives 1.9 Ethical, Legal, and HIPAA Considerations for Radiation Therapists 1.10 Infection Control & Sterile Technique in Radiation Therapy 1.11 Transfer & Positioning Safety for Oncology Patients 1.12 Pharmacology & Contrast Media in Radiation Therapy 1.13 Cancer Epidemiology, Screening & Diagnostic Evaluation
2 Chapter 2: Radiation Physics, Radiobiology & Protection
2.1 Structure of Matter, Electromagnetic & Particulate Radiation 2.2 Radiation Production in Linear Accelerators & X-Ray Tubes 2.3 Photon & Electron Beam Interactions with Matter 2.4 Radiation Measurement Quantities, Units & Dosimeters 2.5 Radiation Protection Principles: ALARA, Time, Distance & Shielding 2.6 NCRP Dose Limits for Occupational & Public Exposure 2.7 Vault Design, Primary & Secondary Protective Barriers 2.8 Radiobiology Principles: Cell Survival Curves & Radiosensitivity (4 R's) 2.9 Linear Energy Transfer (LET) & Relative Biological Effectiveness (RBE) 2.10 Acute & Late Radiation Effects on Normal Tissues 2.11 Radiation Safety Rules, Emergency Procedures & Sealed Source Safety 2.12 MRI Magnetic Field Screening for Radiation Therapy Patients
3 Chapter 5: Treatment Sites, Tumors & Classification
5.1 Brain, Spinal Cord Tumors & Metastatic Patterns 5.2 Head & Neck Sites: Anatomy, Lymphatics & Patterns of Spread 5.3 Breast Cancer: Anatomy, Lymphatic Drainage & Radiation Considerations 5.4 Lung & Thoracic Tumors: Anatomy, Spread & Critical Structures 5.5 Abdomen, Pelvis, GI & GU Sites: Anatomy & Metastatic Patterns 5.6 Reproductive System Tumors: Prostate, Cervix & Related Sites 5.7 Lymphoma, Sarcoma, Skin, Leukemia & Oncologic Emergencies 5.8 Tumor Classification: Histopathology, Grade & Staging Systems
4 Chapter 3: Treatment Planning & Dosimetry
3.1 CT Simulation, Patient Positioning & Target Localization 3.2 Immobilization Devices & Radiopaque Marking Protocols 3.3 ICRU Target Volume Definitions (GTV, CTV, PTV, PRV, OAR) 3.4 Beam Modifiers: Wedges, Compensators, Bolus & MLC Systems 3.5 Depth Dose Characteristics: PDD, TMR, TPR & TAR Relationships 3.6 Monitor Unit (MU) Calculations & Clinical Dosimetry Formulas 3.7 3D Conformal Radiation Therapy (3D-CRT) Beam Arrangements 3.8 IMRT, VMAT & Inverse Planning Optimization Concepts 3.9 SRS, SBRT & Stereotactic Radiosurgery Techniques 3.10 Brachytherapy Principles, HDR, LDR & Isotopes 3.11 Dose Volume Histograms (DVH) & QUANTEC Tissue Tolerances
5 Chapter 4: Treatment Delivery, Image Guidance & QA
4.1 Pre-Treatment Chart Check & Plan Verification Protocols 4.2 Daily Patient Positioning, Setup Tolerances & Alignment Verification 4.3 Image-Guided Radiation Therapy (IGRT): Portal Imaging & CBCT Verification 4.4 Linear Accelerator Safety Systems, Interlocks & Gantry Controls 4.5 Special Techniques: TBI, TSI, SGRT & Gated Radiotherapy 4.6 Daily Linac Quality Assurance per AAPM TG-142 Specifications 4.7 Monthly & Annual Linac QA Requirements & Dosimetric Calibration 4.8 Patient-Specific IMRT QA & In-Vivo Dosimetry Verification 4.9 Machine Malfunctions, Override Protocols & Emergency Off Procedures 4.10 Record and Verify (R&V) Systems, EHR Integration & Treatment Documentation
3.7 3D Conformal Radiation Therapy (3D-CRT) Beam Arrangements
Key Takeaways Explain This Topic AI
3D-CRT utilizes Forward Planning, where the planner manually selects beam angles, field sizes, wedges, and weighting before dose computation.
Parallel Opposed Pairs (POP) deliver uniform dose to deep central structures but create high entry and exit doses in superficial normal tissues.
Four-field box techniques (AP, PA, Right Lateral, Left Lateral) reduce normal tissue dose by spreading entry beams across four orthogonal cardinal angles.
Beam's Eye View (BEV) displays anatomical structures as viewed from the radiation source, allowing precise MLC field shaping around the PTV.
Field-in-Field (FIF) forward planning uses low-weighted sub-fields to eliminate hot spots without physical wedges.
Last updated: July 2026
Principles of Forward Planning in 3D-CRT
Three-Dimensional Conformal Radiation Therapy (3D-CRT) utilizes 3D patient anatomical models generated from CT simulation to shape radiation beam apertures to match target volumes while shielding adjacent healthy organs. 3D-CRT relies on Forward Planning . In forward planning, the dosimetrist or medical physicist manually selects beam angles, beam energies, field sizes, beam modifiers (wedges, blocks, MLCs), and beam weighting factors prior to calculating the resulting 3D dose distribution. If the initial dose distribution does not meet target coverage or normal tissue constraints, the planner must iteratively adjust beam parameters and recalculate dose until an acceptable plan is achieved.
The Forward Planning Step-by-Step Workflow
CT Simulation & Contouring: The patient is imaged in treatment position with immobilizers and radiopaque markers. The radiation oncologist delineates Gross Tumor Volume (GTV), Clinical Target Volume (CTV), Planning Target Volume (PTV), and Organs at Risk (OARs) on axial CT slices.
Isocenter Placement: The treatment planning system (TPS) places the central reference isocenter, typically at the geometric center of the PTV.
Beam Angle & Field Aperture Selection: Beams are arranged using Beam's Eye View (BEV) visualization. Multi-Leaf Collimators (MLCs) or custom alloy blocks shape beam margins around the PTV (typically adding 5–10 mm margins for beam penumbra).
Dose Calculation & Plan Evaluation: Advanced 3D algorithms (e.g., Collapsed Cone Convolution, Monte Carlo) calculate dose. The plan is evaluated using 3D isodose displays and Dose-Volume Histograms (DVHs).
Coplanar vs. Non-Coplanar Beam Geometry
Radiation beam arrangements in 3D-CRT are classified based on the spatial orientation of their central axes relative to the patient's transverse anatomical plane. [ Coplanar Beams ] [ Non-Coplanar Beams ]
- Couch Angle = 0° (Fixed Transverse) Couch Rotation ≠ 0° (e.g., 45°, 90°, 315°)
- Beams intersect in single axial plane Beams enter out-of-plane, spreading entrance dose
- 1. Coplanar Beams
All beam central axes lie within the same 2D transverse anatomical plane. The patient treatment couch remains at 0 ∘ 0^\circ 0 ∘ (or 180 ∘ 180^\circ 18 0 ∘ ) while the gantry rotates around the patient's long axis.
Advantages: Simple, reproducible patient positioning and setup; straightforward visual verification; zero risk of gantry-couch or gantry-patient mechanical collision.
Limitations: Concentrates entrance and exit doses within a single cross-sectional anatomical slice.
2. Non-Coplanar Beams
Created by rotating the treatment couch away from 0 ∘ 0^\circ 0 ∘ (e.g., couch angles of 45 ∘ 45^\circ 4 5 ∘ , 90 ∘ 90^\circ 9 0 ∘ , or 315 ∘ 315^\circ 31 5 ∘ ), allowing beam central axes to enter the patient from out-of-plane directions.
Advantages: Spreads entrance and exit radiation doses over a much larger 3D volume of normal tissue, significantly reducing cumulative dose along any single entry path. Essential for cranial target localization (e.g., brain tumors near the optic chiasm or brainstem) and pediatric cases.
Limitations: Requires strict manual collision checks between gantry head and treatment couch prior to beam delivery; increased setup complexity.
- Classic 3D-CRT Beam Arrangements Parallel Opposed Pair (POP) 4-Field Box Technique Tangential Breast Pair
- [ AP Field ] [ AP Field ] \ Lateral Tangent
- | | \ (Breast)
- +---------------+ +---------------+ +---+----\
- | Target Vol | [Right] | Target Box | [Left] | Target |
- +---------------+ ---> +---------------+ <--- +--------+
- | | /
- [ PA Field ] [ PA Field ] / Medial Tangent
- 1. Parallel Opposed Pair (POP)
Two beams oriented 180 ∘ 180^\circ 18 0 ∘ apart (e.g., AP/PA or Right Lateral/Left Lateral).
Dosimetric Characteristics: Simple setup with broad target coverage. High photon energies ( 10 − 18 MV 10 - 18\text{ MV} 10 − 18 MV ) produce a homogeneous dose distribution across deep structures. However, at lower energies ( 6 MV 6\text{ MV} 6 MV ), POP creates an "hourglass" dose distribution with peak doses ( d max d_{\max} d m a x ) located near superficial skin surfaces.
2. Four-Field Box Technique
Consists of four orthogonal fields: Anterior-Posterior (AP), Posterior-Anterior (PA), Right Lateral, and Left Lateral, all intersecting at a single central isocenter.
Clinical Applications: Pelvic carcinomas (prostate, cervix, endometrium, rectum).
Dosimetric Characteristics: Delivers a uniform rectangular box of high dose to deep pelvic structures while substantially sparing superficial anterior, posterior, and lateral healthy tissues compared to 2-field POP arrangements.
3. Tangential Breast Technique
Employs medial and lateral tangential fields positioned across the chest wall or intact breast tissue.
Dosimetric Characteristics: Gantry and collimator angles are aligned to create a coplanar posterior field border. This prevents radiation beam divergence into underlying pulmonary parenchyma (lung) and myocardium (heart). Physical or dynamic wedges are routinely applied to compensate for the tissue thickness gradient from the breast apex to base.
4. Wedge Pair Technique
Two beams separated by an angle θ \theta θ (hinge angle < 180 ∘ < 180^\circ < 18 0 ∘ , typically 60 ∘ − 90 ∘ 60^\circ - 90^\circ 6 0 ∘ − 9 0 ∘ ).
Dosimetric Characteristics: Physical wedges are placed with their thick heels adjacent to each other. This counterbalances non-uniform dose falloff, producing a homogeneous high-dose region across target volumes (e.g., maxillary sinus, parotid gland tumors).
Hinge Angle Formula: The required wedge angle ( W W W ) is calculated as: W = 90 ∘ − θ 2 W = 90^\circ - \frac{\theta}{2} W = 9 0 ∘ − 2 θ
- Beam Weighting and Dose Normalization
- Unequal Beam Weighting
Assigning different relative monitor units (MUs) or weightings to individual treatment fields (e.g., 2:1 AP:PA or 1.5:1 lateral:AP). Used to compensate for asymmetrical target depth, off-center tumor placement, or proximity of critical normal tissue structures.
Dose Normalization Methods
Isocenter Normalization: Prescribing 100% of the dose to the central axis isocenter ( D iso D_{\text{iso}} D iso ).
Isodose Surface Normalization: Prescribing dose to a specific encompassing isodose line (e.g., 95% or 100% isodose surface) to guarantee full target coverage.
ICRU Criteria for Hot and Cold Spots (ICRU 50 & 62)
The International Commission on Radiation Units and Measurements (ICRU) Report 50 and 62 establish standardized criteria for target volume coverage and dose uniformity in 3D-CRT.
ICRU Dose Metric ICRU Standard Criteria Clinical Significance
Target Uniformity 95% to 107% of Prescribed Dose Mandatory target coverage window ( + 7 % / − 5 % +7\% / -5\% + 7%/ − 5% )
Hot Spot Limit < 107 % < 107\% < 107% of Prescribed Dose High-dose region outside PTV; volume > 15 mm 2 > 15\text{ mm}^2 > 15 mm 2 ( 0.5 cm 3 0.5\text{ cm}^3 0.5 cm 3 )
- Cold Spot Limit > 95 % > 95\% > 95% of Prescribed Dose Under-dosed region within PTV; risk of tumor recurrence
- Reference Point Center of PTV / Beam Intersection Clinically relevant point in uniform dose region
Hot Spot: An area outside the target volume receiving a dose higher than 100% of the prescribed dose. According to ICRU guidelines, a hot spot is clinically significant only if its minimum dimension exceeds 15 mm 2 15\text{ mm}^2 15 mm 2 (or volume > 0.5 cm 3 > 0.5\text{ cm}^3 > 0.5 cm 3 ). Hot spots must not exceed 107% of the prescription dose to avoid normal tissue necrosis.
Cold Spot: A volume within the PTV receiving less than 95% of the prescribed dose. Cold spots present a grave clinical risk of local treatment failure and tumor recurrence.
ICRU Reference Point Requirements: Must be located at the center of the PTV, at the intersection of beam central axes, and within a region of uniform dose where dose calculation accuracy is maximum.